A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

Nature Genetics
S RoperoManel Esteller

Abstract

Disruption of histone acetylation patterns is a common feature of cancer cells, but very little is known about its genetic basis. We have identified truncating mutations in one of the primary human histone deacetylases, HDAC2, in sporadic carcinomas with microsatellite instability and in tumors arising in individuals with hereditary nonpolyposis colorectal cancer syndrome. The presence of the HDAC2 frameshift mutation causes a loss of HDAC2 protein expression and enzymatic activity and renders these cells more resistant to the usual antiproliferative and proapoptotic effects of histone deacetylase inhibitors. As such drugs may serve as therapeutic agents for cancer, our findings support the use of HDAC2 mutational status in future pharmacogenetic treatment of these individuals.

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Y ArcherR A Hodin
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Mar 4, 2000·Nature Genetics·S A GaytherC Caldas
Aug 11, 2001·Science·T Jenuwein, C D Allis
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Mar 7, 2003·The New England Journal of Medicine·Henry T Lynch, Albert de la Chapelle
Jan 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yurij IonovJohn K Cowell
Jan 21, 2004·Nature Reviews. Cancer·Andrew P Feinberg, Benjamin Tycko
Feb 21, 2004·Methods in Enzymology·Andrew J Bannister, Tony Kouzarides
Jun 29, 2004·The Journal of Biological Chemistry·Jesus EspadaManel Esteller
Mar 2, 2005·Cell Cycle·Paul A Marks, Xuejun Jiang
Jul 1, 2005·Nature·David B SeligsonSiavash K Kurdistani
Jul 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mario F FragaManel Esteller
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Melinda C MyzakRoderick H Dashwood

❮ Previous
Next ❯

Citations

Jan 24, 2012·Journal of Chemical Information and Modeling·Subha Kalyaanamoorthy, Yi-Ping Phoebe Chen
May 12, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Katsuhiko NoshoShuji Ogino
Oct 15, 2010·Nature Biotechnology·Anna Portela, Manel Esteller
Oct 8, 2008·Nature Clinical Practice. Oncology·Omar Khan, Nicholas B La Thangue
Jun 28, 2008·Nature Genetics·Anne Hansen ReeKjersti Flatmark
Mar 10, 2011·Nature Medicine·Manuel Rodríguez-Paredes, Manel Esteller
Jul 8, 2011·Nature Reviews. Cancer·Anne Y Lai, Paul A Wade
Feb 10, 2010·Nature Reviews. Clinical Oncology·Eduardo Vilar, Stephen B Gruber
Feb 23, 2008·Nature Reviews. Molecular Cell Biology·Xiang-Jiao Yang, Edward Seto
Aug 19, 2007·Oncogene·M A Glozak, E Seto
Mar 14, 2008·The New England Journal of Medicine·Manel Esteller
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Michael HaberlandEric N Olson
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Oliver M DoveyShaun M Cowley
Jan 11, 2012·Antioxidants & Redox Signaling·Paul V LicciardiTom C Karagiannis
Feb 12, 2009·Genome Research·Agustin F FernandezManel Esteller
Aug 29, 2006·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ana C D'Alessio, Moshe Szyf
Oct 9, 2008·Annual Review of Pathology·Christine A Iacobuzio-Donahue
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eduardo VilarStephen B Gruber
May 23, 2013·Investigative Ophthalmology & Visual Science·Jie FanCraig E Crosson
Oct 12, 2010·Journal of Hematology & Oncology·Antonio SaccoAldo M Roccaro
Dec 7, 2011·Drugs·Sang-Hyun SongYung-Jue Bang
Nov 30, 2011·Epigenomics·Antonio SaccoAldo M Roccaro
Dec 1, 2011·Epigenomics·Inge VerbruggeMichael Bots
Jun 22, 2012·World Journal of Gastroenterology : WJG·Hiroyuki YamamotoYasuhisa Shinomura
Apr 20, 2014·World Journal of Gastroenterology : WJG·Hiroyuki YamamotoFumio Itoh
Mar 28, 2013·Journal of Drug Delivery·Eleftheria Hatzimichael, Tim Crook
Mar 16, 2012·Future Medicinal Chemistry·F CherblancM J Fuchter
Oct 10, 2013·Human Genetics·Laia Simó-Riudalbas, Manel Esteller
May 9, 2012·Cellular and Molecular Life Sciences : CMLS·Alexandra Kollara, Theodore J Brown
Sep 30, 2008·Journal of Cancer Research and Clinical Oncology·Elena GrauVictoria Castel
Oct 17, 2014·Nutrients·Shalome A Bassett, Matthew P G Barnett
Apr 13, 2007·Expert Review of Anticancer Therapy·Douglas Marchion, Pamela Münster
Mar 15, 2015·Expert Opinion on Biological Therapy·Stefan SwierczynskiDaniel Neureiter
Aug 7, 2010·Expert Opinion on Investigational Drugs·Paul A Marks
May 6, 2015·Expert Opinion on Investigational Drugs·Victor Y Yazbeck, Steven Grant
Apr 28, 2007·Expert Opinion on Investigational Drugs·Walid K RasheedH Miles Prince
Feb 26, 2016·British Journal of Cancer·Elena Ceccacci, Saverio Minucci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.